Fruquintinib – Talk Bio

Actionable Insights Powered by AI

HUTCHMED Withdraws Fruquintinib Application for Second-Line Gastric Cancer Treatment in China

HUTCHMED, fruquintinib, gastric cancer, second-line treatment, China, NDA withdrawal